Cargando…
m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism
Glycolytic reprogramming is one of the most important features of cancer and plays an integral role in the progression of cancer. In cancer cells, changes in glucose metabolism meet the needs of self-proliferation, angiogenesis and lymphangiogenesis, metastasis, and also affect the immune escape, pr...
Autores principales: | Yue, Shi-Wei, Liu, Hai-Ling, Su, Hong-Fei, Luo, Chu, Liang, Hui-Fang, Zhang, Bi-Xiang, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426175/ https://www.ncbi.nlm.nih.gov/pubmed/37582735 http://dx.doi.org/10.1186/s12943-023-01841-8 |
Ejemplares similares
-
BRD9 is an essential regulator of glycolysis that creates an epigenetic vulnerability in colon adenocarcinoma
por: Zhu, Qunshan, et al.
Publicado: (2022) -
m(6)A-dependent glycolysis enhances colorectal cancer progression
por: Shen, Chaoqin, et al.
Publicado: (2020) -
Rna M(6)a Methylation Regulates Glycolysis of Beige Fat and Contributes to Systemic Metabolic Homeostasis
por: Li, Yu, et al.
Publicado: (2023) -
HKDC1 promotes the tumorigenesis and glycolysis in lung adenocarcinoma via regulating AMPK/mTOR signaling pathway
por: Wang, Xinyu, et al.
Publicado: (2020) -
METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10
por: Cai, Jingli, et al.
Publicado: (2022)